Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
78.03
+0.73 (0.94%)
Dec 24, 2025, 1:00 PM EST - Market closed
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $5.27 billion as of December 24, 2025. Its market cap has increased by 88.74% in one year.
Market Cap
5.27B
Enterprise Value
4.69B
1-Year Change
88.74%
Ranking
Category
Stock Price
$78.03
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $5.27B, an increase of 551.53%. That is a compound annual growth rate of 114.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 5.27B | 104.45% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
| Jul 14, 2023 | 808.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 963.86B |
| Johnson & Johnson | 499.50B |
| AbbVie | 402.80B |
| UnitedHealth Group | 294.54B |
| AstraZeneca | 284.34B |
| Novartis AG | 263.31B |
| Merck & Co. | 259.92B |
| Abbott Laboratories | 217.70B |